SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Palo Alto’s CEO bought the dip. Five months later, his $10 million bet is worth $26 million

Why Anthropic is willing to pay $6 billion for Decart

Izaki Group buys 60-dunam Ra’anana site for $85 million

“AI doesn’t fundamentally change cybersecurity. It changes the speed and scale”

Buzz

Most popular

Daily

Weekly

1

LinkedIn to shut down Israeli R&D operations and lay off nearly all employees

2

Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling

3

Covenant takes its long-range missile from secrecy to a live-fire test in Morocco

4

Corma raises $60 million Seed to build AI designed to fight AI-powered cyberattacks

5

Anthropic in talks to acquire Israeli AI startup Decart for $6 billion

Prof. Shay Ben Shachar

1 stories about Prof. Shay Ben Shachar

כנס TECH TLV - פרופ' שי בן שחר רופא ילדים ומנהל המחלקה לרפואה מותאמת אישית גנומית בכללית וידאו

“It will be possible to test a person at age 18 and, using data, anticipate what medical care they are likely to need decades later”

09.02.26|Tomer Hadar

Prof. Shay Ben Shachar, Director of Precision Medicine and Genomics at Clalit Innovation, was speaking at the Calcalist Tech TLV Conference held in collaboration with Leumi.